The University of Texas Medical Branch, Galveston

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, The University of Texas Medical Branch, Galveston sits in the top decile of US sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count).

203 total trials 29 currently recruiting 117 completed early-phase tilt top decile by trial count

The University of Texas Medical Branch, Galveston: 203 sponsored US clinical trials, 29 recruiting.

The University of Texas Medical Branch, Galveston sponsors 203 registered US clinical trials on ClinicalTrials.gov, 29 of them currently recruiting, and 117 completed. 19 of these trials are in Phase 3-4 (later-stage) and 51 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 4 trials.

Top-decile sponsor footprint

The University of Texas Medical Branch, Galveston ranks in the top decile of sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 25/100

117 of 157 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (74.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

203 total, page 1 of 5

RECRUITING NA

Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment

NCT07416799

RECRUITING Phase 2

Tirzepatide to Slow Biological Aging

NCT07220473

RECRUITING NA

Improving Sleep In Midlife Women

NCT07337915

RECRUITING NA

Stimulation of External Carotid Artery Circulation

NCT07402954

RECRUITING NA

Vibratory Anesthesia on Pain Following Corticosteroid Injections

NCT07553273

RECRUITING Phase 2

Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage

NCT07294118

RECRUITING

The Metabolic and Genetic Drivers of Body Composition Changes Following Weight Loss Surgery

NCT07178704

RECRUITING NA

Pain Intervention With Needling: Pilot Of Integrated Neuromodulation Techniques

NCT07112404

RECRUITING Phase 4

Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

NCT07203287

RECRUITING NA

Optimizing Gait Symmetry After Stroke Using Mechanical Constraints and Sensory Feedback

NCT07087769

RECRUITING NA

Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab

NCT07087743

RECRUITING NA

Explore the Effects of Cortical Priming on Visuomotor Stepping Learning in Persons With Chronic Stroke

NCT06681207

RECRUITING NA

The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms

NCT06607523

RECRUITING Phase 3

Novel Strategies for Reducing Burn Scar Itch

NCT06801626

RECRUITING NA

Wearable Echolocation Aids Using Parametric Sound

NCT07218991

RECRUITING NA

Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study

NCT06347796

RECRUITING NA

THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation

NCT06395506

RECRUITING NA

Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.

NCT06737432

RECRUITING NA

Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery

NCT06162052

RECRUITING

Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

NCT06098404

RECRUITING NA

Promoting Intergenerational Health in Rural Kentuckians With Diabetes (PIHRK'D)

NCT06080425

RECRUITING NA

Healthy Communities Through CHW Initiatives

NCT05965869

RECRUITING

The Gut Microbiome and Immunotherapy Response in Solid Cancers

NCT06050733

RECRUITING NA

Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain

NCT05555485

RECRUITING Phase 2

Viral Mucosal Reprogramming

NCT05331170

RECRUITING Phase 4

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

NCT05672927

RECRUITING

Understanding the Burn Wound Microbiome: Comparing Traditional Wound Cultures to Next Generation Sequencing Technology

NCT05275335

RECRUITING NA

Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms.

NCT05147831

RECRUITING Phase 2

Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries

NCT04565925

ACTIVE NOT RECRUITING NA

Brain Stimulation Enhance Post-stroke Walking Survivors and Healthy Adults

NCT06191549

ACTIVE NOT RECRUITING Early Phase 1

Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls

NCT05880862

ACTIVE NOT RECRUITING Phase 2

A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia

NCT05815485

ACTIVE NOT RECRUITING NA

Measuring Relative Afferent Pupillary Defect

NCT05799066

ACTIVE NOT RECRUITING NA

Evaluating Telementoring for CHW-centered Diabetes Initiatives

NCT04835493

ACTIVE NOT RECRUITING

Microbiome and Immunosuppression: The Mission Study

NCT04953715

ACTIVE NOT RECRUITING NA

A Social Media Game to Increase Physical Activity Among Older Adult Women

NCT04095923

ACTIVE NOT RECRUITING Phase 4

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

NCT03943875

ACTIVE NOT RECRUITING Phase 1

Use of Sildenafil for Treatment of Urinary Incontinence

NCT02983461

ACTIVE NOT RECRUITING

Natural History of Shoulder Pathology in Manual Wheelchair Users

NCT02600910

ACTIVE NOT RECRUITING

Acute Porphyria Biomarkers for Disease Activity

NCT02935400

NOT YET RECRUITING

Identification of Neuromusculoskeletal Variables Associated With Injury Risk and Performance in High School Athletes.

NCT04095260

NOT YET RECRUITING Phase 2

Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment

NCT06800092

NOT YET RECRUITING NA

No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women

NCT06376812

NOT YET RECRUITING NA

Feasibility of A Smartphone Application Intervention in Community Settings: A Pretest-Posttest Pilot Study

NCT07313540

NOT YET RECRUITING Early Phase 1

Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.

NCT06864689

NOT YET RECRUITING Phase 1

Nanopulse Laser Therapy

NCT07520383

COMPLETED NA

Safety and Acceptability Study of a Placebo Antibody-Based Nonhormonal Contraceptive Intravaginal Ring

NCT06740253

TERMINATED NA

Weighted Blanket to Treat Anxiety Related to Trying New Foods the Pediatric Population

NCT06420232

COMPLETED NA

Effects of Rehabilitation Robots-Morning Walk in Individuals With Hemiparesis

NCT06374706

COMPLETED NA

Retroperitoneal Tunneling Versus Dissection Technique During Sacrocolpopexy

NCT05969067

Page 1 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 24
Phase 2 27
Phase 3 4
Phase 4 15

What is open in the The University of Texas Medical Branch, Galveston pipeline

29 recruiting of 203 indexed (14% open); 117 completed (58%).

Phase mix: 19 late (III/IV) vs 51 early (I/II) (early-phase heavy).

Top condition: Stroke (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

The University of Texas Medical Branch, Galveston: open-pipeline peers nationwide

Peers matched on 203 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200250 0%5%10%15%20% Total trials Recruiting share The University of Texas Medical Branch, GalvestonNational Center for Complementary and Integrative Health (NCCIH)MedImmuneGenzyme, a Sanofi CompanyOHSU Knight Cancer InstituteAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 203 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this The University of Texas Medical Branch, Galveston page

203 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Medical Branch, Galveston or any single study.

  • 29 of The University of Texas Medical Branch, Galveston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition The University of Texas Medical Branch, Galveston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

The University of Texas Medical Branch, Galveston pipeline card: 203 registered trials from official public datasets.Report a data error.